Aerie Pharmaceuticals and GrayBug Announce Research Collaboration | Business Wire
Aerie Pharmaceuticals (AERI) Stock | Helping Treatment with Glaucoma - Warrior Trading News
Durham-based Aerie Pharma is sold to global eye care giant in deal worth $770M - Research Triangle Regional Partnership
Aerie Pharma (AERI) Falls on Glaucoma Eye Drop Safety Concerns - TheStreet
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results | Business Wire
Aerie Pharma Dips On 'Minor' Glaucoma Setback And Q3 Miss | Stock News & Stock Market Analysis - IBD
Aerie Pharma Seeks FDA Nod to Sell Ireland-based Product in US | INN
Aerie Pharma slips after announcing eye disease trial failed to meet primary endpoints | Seeking Alpha
Articles about Aerie Pharmaceuticals, Inc.
Alcon ups its glaucoma game again with $770M Aerie Pharma acquisition - MedCity News
Aerie Pharma Re-Ups In Irvine, CEO Departs - Orange County Business Journal
AeriePharma (@AeriePharma) / X
Aerie Pharmaceuticals Inc (AERI) - Financial and Strategic SWOT Analysis Review
Aerie Pharmaceuticals Enters into Lease Agreement for New Manufacturing Plant in Ireland - Pharma Advancement
Aerie Pharma appoints Richard Rubino as CFO | Healthcare Digital
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021 | Business Wire
Aerie Pharmaceuticals | Capital Sign Solutions
Aerie Pharmaceuticals to Merge with Global Eye-Care Company Alcon | North Carolina Biotechnology Center
Aerie Pharmaceuticals - Crunchbase Company Profile & Funding
Aerie Pharmaceuticals Inc. Company Profile - The Business Journals
Aerie Pharmaceuticals | PPT
AERIE PHARMACEUTICALS, INC. - Aerie Pharmaceuticals, Inc. Trademark Registration
Aerie Pharmaceuticals | LinkedIn
Aerie Pharmaceuticals (AERI) Axitinib Implant (AR-14034) Overview - Slideshow (NASDAQ:AERI) | Seeking Alpha
Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer | Business Wire
